GlassScriptSpaceoar Vue System - 10ml
Payments companies reported to CMS as associated with Spaceoar Vue System - 10ml. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Spaceoar Vue System - 10ml, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Spaceoar Vue System - 10ml
These are the largest totals companies reported as associated with Spaceoar Vue System - 10ml. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Paul Nguyen | Boston, MA | Radiation Oncology | $163,957.61 |
| Brian Baumann | Springfield, IL | Radiation Oncology | $45,884.78 |
| Michael Zelefsky | New York, NY | Radiation Oncology | $45,707.95 |
| Albert Chang | Los Angeles, CA | Radiation Oncology | $44,701.82 |
| Parthiv Mehta | Glenview, IL | Radiation Oncology | $38,137.51 |
| Neil Taunk | Philadelphia, PA | Radiation Oncology | $29,126.76 |
| Akash Nanda | Orlando, FL | Radiation Oncology | $16,739.28 |
| Marcio Fagundes | Miami, FL | Radiation Oncology | $16,148.08 |
| Dean Laganosky | Plymouth Meeting, PA | Urology | $10,702.20 |
| Daniel Fried | Spartanburg, SC | Radiation Oncology | $7,986.70 |
Prescribed Spaceoar Vue System - 10ml?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.